This free workshop is for professionals who work with parents and children and will help you cut through the noise and better understand RSV and it's implications for children ages 0-3 years old.

The “cold and flu” season is challenging for all of us! Children under three years, especially infants and those who were born prematurely or are medically fragile (congenital heart disease, chronic lung disease or specific respiratory or immune conditions) are at significantly increased risk of being admitted to the hospital should they become ill.

We'll also hear from the Canadian Premature Babies Foundation and their recent position paper on the cost-effectiveness of Palivizumab in late preterm babies.

The presentations will address the risks of RSV and how parents and professionals can balance decreasing the risks and “having a life”. 


About the speakers:

Barry Rodgers-Gray: 

Barry Rodgers-Gray holds a PhD and has worked in medical education and communications for 20 years. He first worked on RSV in 2003 and has since been involved in over 30 publications. Notable work includes being part of an international expert group that developed and validated the International Risk Scoring Tool for identifying infants born 32-35 weeks’ gestational age at greatest risk of RSV hospitalisation. Barry was also one of the investigators on the EROS study that assessed the burden to parents of having a child hospitalised with RSV. Barry is a member of the PROUD Taskforce of 24 RSV global experts assembled to help identify solutions to the burden of RSV in low-and middle-income countries.

Fabiana Bacchini

Fabiana Bacchini is a mother of a surviving twin born at 26 weeks gestation and the Executive Director of the Canadian Premature Babies Foundation. She is a journalist and the published author of From Surviving to Thriving, a Mother’s Journey Through Infertility, Loss and Miracles.

This event was made possible thanks to the support of